Sunday, 8 December 2013

Anesthesia Devices Market and Respiratory Devices Market is Expected to Reach USD 21.6 Billion Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research "Anesthesia and Respiratory Devices Market (Anesthesia Workstation, Anesthesia Delivery Machines, Ventilators, Monitors, Nebulizers & Respiratory Inhalers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global anesthesia and respiratory devices market was valued at USD 11.2 billion in 2012 and is expected to grow at a CAGR of 9.8% from 2013 to 2019, to reach an estimated value of USD 21.6 billion in 2019.


A rise in healthcare expenditures witnessed globally has led to a shift in preference from hospital care to home care among patients. This rise in healthcare cost, compounded by the geriatric population, is driving the demand for portable medical diagnostic devices including respiratory and anesthesia devices. This has led to a visible shift in the use of respiratory and anesthesia devices from hospital operation set ups to home care healthcare monitoring. Moreover, a rise in respiratory diseases such as asthma, lung cancer, COPDs (Chronic Obstructive Pulmonary Diseases) and OSA (Obstructive Sleep Apnea) have triggered the growth of this market. There has also been an exponential rise in number of surgical procedures globally and this has led to a significant growth in demand for anesthesia devices and delivery machines. Growing healthcare cost containment pressure in the U.S. and the ongoing Euro crisis have caused a slump in the growth of these markets. Tax reforms coupled with increased regulatory compliance norms are also restraining the growth and profitability of top companies. The tax reform under question has proposed the levy of a 2.3% tax on the annual sale of all the medical devices manufacturers since beginning of this year i.e. 2013.


This has made it imperative for OEMs to tap the potential market in emerging economies such as India, China, Brazil and Russia. There has been significant growth in these emerging economies owing to increase healthcare awareness, rising disposable incomes and a rising middle class coupled with favorable insurance policies in these countries. This in turn is anticipated to make these regions the most attractive markets during the forecast period from 2011 to 2019.


Saturation in western countries, especially the U.S. and Europe, coupled with unfavorable taxation policies has negatively affected the growth of the market in these regions. Companies are now vying for growth in emerging markets namely India,China and Brazil. The major players in this industry are also facing stiff competition from the regional manufacturers of these countries. However, robust R&D and continuous innovation has helped the big players of this market to retain their strong position in the market. In addition manufacturers such as GE Healthcare, Philips Healthcare, Teleflex and Drager have created a strong brand image with high end quality products supporting their strong market position.


The report covers in-depth analysis of estimation of anesthesia and respiratory devices market, for the period from 2013 to 2019, considering 2012 as the base year for calculations. In addition, the current market dynamics including the drivers, restraints, trends and recent developments has been captured throughout the report. The respiratory devices market has been further bifurcated under respiratory devices, respiratory disposables and respiratory measurement devices. This market has been further segmented by the respective types of devices. The anesthesia devices market has been split broadly under anesthesia machines and disposables. 
Anesthesia devices include anesthesia machines and anesthesia disposables. The anesthesia machines account for the largest market of the total anesthesia devices market. The market for anesthesia delivery machines was valued to be the highest in year 2012. However, the anesthesia monitors market is expected to grow at a higher CAGR of above 8.0% from 2013 to 2019. The respiratory devices market includes respiratory equipments, disposables and respiratory measurement devices. The respiratory equipments include humidifiers, nebulizers, oxygen concentrators, positive airway pressure devices, ventilators and inhalers. The positive airway pressure devices market is expected to foresee the highest growth in the coming years of forecast from 2013 to 2019.


The geographic chapter spans the major regions including North America, Europe, Asia and ROW (Rest of World). Similarly, market share analysis for global market for respiratory and anesthesia devices together has been provided in the competitive landscape chapter. In addition we have also separately provided the market share analysis for respiratory and anesthesia devices respectively. Some of the major players in this market are GE Healthcare, Drager, Fischer & Paykel, Covidien, Teleflex Incorporated, Philips Healthcare, ResMed and others. These market players have been profiled on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability financial overview and recent developments. Our chapter on recommendations provides an understanding of barriers to the market entry and success strategy to be considered for growth in this market. 

Blogs:

Thursday, 5 December 2013

Medical Tourism: Treatments, Markets and Health System Implications: A scoping review

Transparency Market Research is Published new Market Report "Medical Tourism Market (India, Thailand, Singapore, Malaysia, Mexico, Brazil, Taiwan, Turkey, South Korea, Costa Rica, Poland, Dubai and Philippines) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" The global medical tourism market was valued at USD 10.5 billion in 2012 and is estimated to reach a market worth USD 32.5 billion in 2019 at a CAGR of 17.9% from 2013 to 2019.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/medical-tourism.html

Medical tourism is defined as an act of travel of patients from their home country to other destinations for availing medical services. Rise in healthcare costs in developed countries coupled with the availability of high quality medical services at a low cost in developing countries have given a boost to the medical tourism industry. These medical services range from elective procedures such as cosmetic surgeries to complicated surgeries such as cardiac, orthopedics, neurosurgery and others. Significant growth in this industry is due to economic developments in developing countries that in turn has led to the growth in the medical industry and quality of medical services.

Rise in the healthcare expenditure in developed countries coupled with in the growing elderly population has also contributed to the gowth of the medical tourism across the globe. Economic crisis in the U.S. increased the number of uninsured population, consequently further triggering the growth of this market. Recently, there are approximately 50 million uninsured Americans that are willing to travel abroad for affordable and quality medical care. Globalization and improved communication technology act as a catalyst to boost the growth of this industry.

The development of medical tourism industry is based on several factors such as reduced cost of procedures, long waiting time and high demand for cosmetic surgeries. Medical travel is not only witnessed for intricate procedures but is also expanding due to growing demand for cosmetic and dental procedures since these are usually not reimbursed under regular health insurance policies. Patients travelling abroad can save from 30% to 90% on a procedure, including their travel expenditures, as compared to the medical costs in their own countries. Long waiting time is another factor which has substantially boosted the growth of this industry. Patients based in Canada and U.K travel to low cost destinations for their treatments in order to avoid long waiting periods in their own countries and receive timely access to serious ailments.

Medical tourism industry is dominated by the Asian region that has captured the maximum share of the market. This region is highly competitive owing to the presence of technologically advanced medical specialties, less stringent government regulations and attractive locations. Thailand and India are recognized internationally for their high end medical services and receive patients from across the globe. Singapore is renowned for its healthcare infrastructure and receives patients primarily for complex medical procedures. Thailand, India and Singapore accounted for approximately 60% of the total revenue of the Asian region in 2012. The Latin American countries such as Brazil and Mexico attract maximum number of patients from the U.S owing to the geographic proximity and cultural similarities. Similarly, growth in Turkey is witnessed on account of growing demand of cosmetic surgeries.

However, a paradigm shift in the market is seen owing to strong competition among the players of this industry. Malaysia is poised to have a significant growth in this market and is likely to emerge as a fastest growing country in terms of medical tourism with a CAGR of over 25% from 2013 to 2019. This advent in Malaysian medical tourism market is due to cost advantage over Thailand and Singapore. Moreover, rise in popularity of Malaysian region is attributed to many factors such as advanced healthcare infrastructure, highly skilled professionals, visa benefits and others. Additionally, robust government support for promotion of Malaysian medical tourism has propelled the growth in this nation.

Moreover, increase in the government initiatives and growing inclination of private sector hospitals towards medical tourism is further supplanting the growth of this market. Key healthcare providers in this industry include Apollo Hospitals Enterprise Ltd., Bumrumgrad International Hospital, Bangkok Medical Center, Prince Court Medical Center and others.

The Medical Tourism market is segmented as follows:
The global medical tourism market is segmented into the following categories:

  • Medical Tourism Market, by Geography
    • India
      • Overview
      • Cost Comparison of Procedures
      • SWOT Analysis
      • Government Support
      • India Inbound Medical Tourism (No. of patients)
      • India Medical Tourism: Top Revenue Contributing Country (%) (2012)
    • Thailand
    • Singapore
    • Malaysia
    • Mexico
    • Brazil
    • Turkey
    • South Korea
    • Taiwan
    • Prospective Countries
      • Costa Rica
      • Poland
      • Dubai
      • Philippines

Tuesday, 3 December 2013

Cell Surface Markers Market is Expected to Reach USD 23.03 Billion Globally in 2019: Transparency Market Research

Transparency Market Research published new market report "Cell Surface Markers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global cell surface markers market was valued at USD 13.2 billion in 2012 and is expected to grow at a CAGR of 8.1% from 2013 to 2019, to reach an estimated value of USD 23.03 billion in 2019.


Cell surface markers are expressed on the surface of cells and function as identifiers of certain type of cells. The presence of cell markers also assists in the determination of cell type expression of specific receptors vital for biological response. Cell surface marker analysis is also essential in determination of experimental drug or ligand response. Rapid development in healthcare technology, growing preference for reduction of healthcare expenditure by lowering the cost of diagnosis, reduction in the risk of misdiagnosis, rapid and efficient decision making for therapies for specific diseases are some of the major factors which support the growing acceptance of cell surface marker analysis worldwide.

Browse full PDF with TOC: Cell Surface Markers Market

On the other hand, complexity of high-end flow cytometers and high cost of reagents, controls and analysis systems result into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries. Increased market consolidation, simplification of analysis products, cost containment of such products and introduction of cheaper products in less developed markets are the major market strategies which are being adopted by the existing and emerging market players to sustain the cell surface markers market.

The global cell surface markers market can be categorized into instruments and reagents, kits and controls used for cell marker analysis. Flow cytometers and hematology analyzers are the prime cell marker analysis equipment used. Flow cytometry is the most prominently used tool for cell marker analysis. Availability of a wide range of flow cytometers and their efficacy in both research and drug discovery are the major factors driving the demand for flow cytometers. It is expected that the global market for flow cytometers will grow at a CAGR of more than 8% from 2013 to 2019 with a cumulative installed base of approximately over 85,000 units by 2019.

Disease diagnosis and identification and research and drug discovery are the two prime application areas of cell surface marker analysis. Cell markers analysis is essential in drug discovery and its use in R&D by pharmaceutical manufacturers and researchers widespread. Thus in terms of allocations, drug discovery and research segment is expected to dominate the global cell surface markers during the given period of forecast.

Geographically, North America is the dominant regional market for cell surface markers with almost half of the market share. Emerging countries of Asia-Pacific, Latin America and Middle-East are expected to undergo rapid market growth by 2019. Improvement in healthcare infrastructure and growing preference for safer and easier targeted therapies are the major factors which will fuel the market growth in these regions.

The cell surface markers market is highly fragmented and consists of many large and small players. The competition in this market is characterized by market consolidation activities, partnerships and intensive mergers and acquisitions. Some of the major companies in the cell surface markers market include Abbott Laboratories, Beckman Coulter, BD Biosciences, Bio-Rad, Seimens Healthcare, Nihon Kohden Corporation, Sysmex Corporation and Roche Diagnostics.

The global cell surface markers market is segmented as follows:

Cell Surface Markers Market, by Instruments and Reagents
  • Flow Cytometers
  • Hematology Analyzers
  • Reagents and Kits

Cell Surface Markers Market, by Applications
  • Disease Diagnosis and Identification
  • Research and Drug Discovery

Cell Surface Markers Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Wednesday, 27 November 2013

Medicine Education Publishing Market - Global Industry Size, Market Share, Trends, Analysis And Forecast 2012-2018

According to the latest market report published by Transparency Market Research "General Medicine Education Publishing Market - Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012-2018", the global publishing market for general medicine education was worth USD 2.45 billion in 2012 and is expected to reach USD 3.6 billion in 2018, growing at a CAGR of 6.8% from 2012 to 2018. In the overall global market, North America is expected to continue its lead position in terms of revenue generation till 2018 with a share of 51.9% of the global market followed by Europe at 30.9%.

Browse the full report: http://www.transparencymarketresearch.com/general-medicine-education-publishing.html

Among the different market segments, custom content publishing segment is estimated to hold maximum share with 57% market share in the total general medicine market. The reason for its high share is the price of publishing custom content material, which is quite high as compared to any other publishing. This is followed by the market for online reference tools such as WebMD (Medscape), MDconsult, Micromedex among many others. Most popular online reference platforms have dedicated subscriptions, which have thus accounted for steady revenue generation. E-books and printed textbooks & reference books account for the third largest share in the general medicine education market.

The major drivers of the market include increase in online education, growth of e-books and need of primary healthcare. Primary healthcare is delivered by specialists in general medicine or internal medicine and are called Internists. The major factors restraining the market are the low adoption rate of online education in developing regions of the world, since a large fraction of population is not exposed to modern technology added to the decreasing number of students opting for medical specializations that brings a higher income.

The key players in the medical publishing market include Reed Elsevier, Wolters Kluwer, Thomson, Mc Graw-Hill, and Optum Health among others. Reed Elsevier is currently considered as overall market leader with popular contributions to books in internal medicine such as Davidson's Principles and Practice of medicine. A comprehensive assessment of key players and their strategies along with winning imperatives have been analyzed in this report by segmenting the market as below:


Electronic & online publishing market for general medicine education

  • Online Reference Tools
  • Mobile Applications
  • Electronic & Digital textbooks and reference books
  • Multimedia Content
  • Testing & Self-Assessmen
  • Hospital Training
  • Distance Learning


Print publishing market for general medicine education

  • Custom content publishing
  • Print textbooks and reference books
  • Testing & Self-Assessment
  • Hospital Training
  • Distance Learning


In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

  • North America
  • EuropeAsia
  • Rest of the World (RoW) 


Monday, 25 November 2013

Healthcare Cloud Computing Market- Global Industry Analysis, Size, Share, Trends and Forecast 2012 – 2018


According to a new market report published by Transparency Market Research "Cloud Computing Market In Healthcare Industry (IaaS, SaaS, PaaS, CIS, NCIS, PACS, EMR, RIS) – Global Industry Analysis, Size, Share, Trends and Forecast, 2012 – 2018" the global cloud computing market in the healthcare industry was valued at USD 1.82 billion in 2011 and is expected to reach USD 6.79 billion by 2018, growing at a CAGR of 21.3% from 2012 to 2018.

Browse full report with TOC: http://www.transparencymarketresearch.com/healthcare-cloud-computing.html

The report provides the market estimate and forecast in terms of revenue for the global cloud computing market in healthcare industry. A detailed analysis of the market trends, current scenarios and future trends from 2012 to 2018 is available in the report. The market is analyzed by using concepts such as market dynamics including drivers, restraints and opportunities along with their impact analysis and market attractiveness analysis. 

The market is segmented on the basis of cloud types into: Public, private and hybrid cloud. A detailed trend analysis of all the segments with market evaluation in terms of revenue generated with respect to the applications and geography is available in this report.

The market is also segmented on the basis of geography into: North America, Europe, Asia and rest of the world (RoW) regions. Geography wise, market evaluation is available in terms of revenue from 2012 to 2018.

A competitive analysis of the market players involved is also available in the report. Some of the major players of this market include: CareCloud, ClearDATA Networks, Merge Healthcare, Agfa Healthcare, IBM Corporation, Microsoft, Carestream Health, Oracle Corporation and others. Company overview, financial overview, business strategies, SWOT analysis, recent developments and product portfolio for each of the market players is also highlighted in the report.

The study presents a comprehensive assessment of the stakeholder strategies and their winning imperatives by segmenting the cloud computing market in healthcare industry as below:

Global cloud computing market in healthcare industry by service models
  • Infrastructure-as-a-Service (IaaS)
  • Platform-as-a-Service (PaaS)
  • Software-as-a-Service (SaaS)

Global cloud computing market in healthcare industry by pricing models
  • Spot pricing or subscription model
  • Pay-as-you-go model

Global cloud computing market in healthcare industry by end user applications
Clinical Information systems (CIS) cloud computing market
  • EMR
  • PACS
  • RIS
  • Others

Non-Clinical Information systems (NCIS) cloud computing market
  • RCM
  • Claims management
  • APB
  • Others

Global cloud computing market in healthcare industry by geography
  • North America
  • Europe
  • Asia
  • RoW

Blogs:
http://usamarketresearch.wordpress.com/
http://pharmaceuticalmarkets.wordpress.com

Friday, 22 November 2013

Global Peptide Therapeutics Market (Industry Analysis, Size, Share, Growth, Trends)- New Market Research Report Published by Transparency Market Research

The Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are actively investing in development of newer peptides for various applications and are also opting for newer technologies for syntheses of these peptides. Cancer is the leading cause of death globally; according to the WHO (World Health Organization), around 12.7 million new cancer cases occurred in the year 2008. About 7 million people die from cancer every year and it is estimated that there will be more than 16 million new cancer cases every year by 2020. With rise in cancer patients and metabolic diseases like diabetes, there has been a push in growth for peptide molecules since chemotherapy, which is the major mode of treatment for cancer, is facing major challenges  due to its inability to deliver the correct amount of drug directly. In addition, it affects the normal cells in the body. 

Browse full Report with TOC: http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Likewise, peptide application in various other treatments has opened a promising avenue for future growth of this market. New routes of peptide administration are being investigated; however the parenteral route continues to dominate this market and accounted for a share of almost 86% of the entire market. Similarly, the technology market is ruled by LPPS (long phase peptide syntheses) and is anticipated to decline owing to huge demand for solid phase peptide syntheses and hybrid syntheses.

This report analyzes the peptide therapeutics market by types of applications (cancer, metabolic, neurological diseases and others), route of administration, by types (innovative and generic), by API therapeutics market (in-house vs. CMO), by peptide therapeutics, and technology. Each of these markets is analyzed by studying the current and future market scenario, with estimation for the period 2010 – 2018 in terms of value in USD million.

The peptide therapeutics market is also segmented based on geography into North America, Europe, Asia and rest of the world (RoW) regions. The market for all these geographical regions is provided in the report in terms of revenue. The report provides complete analysis of the factors responsible for driving and restraining the global peptide therapeutics market. 

Competitive landscape is provided with market players profiled with attributes like company overview, financial overview, business strategies, product portfolio and recent developments. Market shares in 2011 for the key players and CMO players are provided and recommendations to accentuate market shares and ensure sustainability are provided in this report Key market players profiled in this report are Eli Lilly, Roche, Amylin, Novo-Nordisk, Ipsen and others. While CMOs major players profiled are Bachem, Lonza, Peptisyntha, Polypeptide group and others.

Peptide Therapeutics Market, by Applications
Cancer
Metabolic
Cardiovascular
Dermatology
Anti-Infection
Neurology
Gastro Intestinal
Renal 
Respiratory
Pain
Others

Peptide Therapeutics Market, by Route of Administration
Parenteral
Oral
Pulmonary
Mucosal
Others

Peptide Therapeutics Market, by Types
Innovative
Generics

Peptide Therapeutics Market, by API Peptide 
In-House
CMO (Contract Manufacturing Organization)

Peptide Therapeutics by Technology
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Hybrid 

Peptide Therapeutics Market, by Geography
North America
Europe
Asia
RoW

Blogs:
http://usamarketresearch.wordpress.com/
http://pharmaceuticalmarkets.wordpress.com/

Tuesday, 19 November 2013

Global mHealth Market is Expected to Reach USD 10.2 Billion Globally by 2018: Transparency Market Research

Transparency Market Research is Published new Market Report "MHealth Market - Global Mobile Health Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 – 2018” The growth in mHealth market is primarily driven by the increasing adoption of smartphones, rising incidence of chronic diseases and growing number of mHealth applications. Mobile based healthcare services access is becoming almost ubiquitous worldwide. mHealth applications are rapidly gaining popularity due to growth in number of innovative solutions.

Browse full reports with TOC: http://www.transparencymarketresearch.com/mobile-health-market.html

The global mHealth market is segmented by services into: monitoring services, diagnostic services, healthcare system strengthening services and other services. Mobile operators, device vendors, content players and healthcare providers are the various participants of the mHealth market. The market has also been segmented by geography into North America, Europe, Asia Pacific and Rest of the World regions. Market estimates and forecasts are made after critical analysis of various macro and micro economic factors which directly and indirectly affect the market growth. Inclusion of these factors has helped in accurate crunching of numbers and has extended the report purview. The report includes market size estimation and forecasts for the period of 2011 to 2018 for each of the mHealth segments.

The report will support the strategy development of players across the supply chain including device vendors, mobile operators, content developers and healthcare providers. The trends in the mHealth market will help healthcare service providers in tapping the untapped segments and address unmet needs. The competitive landscape section will especially help content developers and healthcare providers in strengthening their position in the market.

An in-depth research and market analysis will allow mobile application developers, marketing companies, healthcare providers, content developers, research and development agencies, network operators, and system integrators to make informed decisions about development, marketing, and growth strategies.